Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity

Francis P. Kuhajda, Gabriele V. Ronnett

Research output: Contribution to journalArticle

Abstract

The rising incidence of obesity, as a disorder of energy metabolism, has provoked a search for pharmacological agents that either increase energy expenditure or reduce food intake. The fatty acid oxidation pathway, and its rate-limiting enzyme carnitine palmitoyltransferase (CPT)-1 are potential targets for the treatment of obesity. The modulation of CPT-1 may simultaneously affect energy metabolism and food intake to aid in the management of obesity. Both the inhibition and enhancement of CPT-1 activity are currently under investigation as strategies for the treatment of obesity. In this review, key data on both sides of the 'CPT-1 activity balance' as they relate to obesity therapy are discussed.

Original languageEnglish (US)
Pages (from-to)312-317
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Volume8
Issue number4
StatePublished - Apr 2007

Fingerprint

Carnitine O-Palmitoyltransferase
Obesity
Energy Metabolism
Eating
Energy Intake
Fatty Acids
Pharmacology
Incidence
Enzymes

Keywords

  • Carnitine palmitoyltransferase-1
  • CPT-1 inhibition
  • CPT-1 stimulation
  • Fatty acid oxidation
  • Feeding behavior
  • Malonyl-CoA
  • Obesity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity. / Kuhajda, Francis P.; Ronnett, Gabriele V.

In: Current Opinion in Investigational Drugs, Vol. 8, No. 4, 04.2007, p. 312-317.

Research output: Contribution to journalArticle

Kuhajda, Francis P. ; Ronnett, Gabriele V. / Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity. In: Current Opinion in Investigational Drugs. 2007 ; Vol. 8, No. 4. pp. 312-317.
@article{58af315e03c14f968af012658ff793b8,
title = "Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity",
abstract = "The rising incidence of obesity, as a disorder of energy metabolism, has provoked a search for pharmacological agents that either increase energy expenditure or reduce food intake. The fatty acid oxidation pathway, and its rate-limiting enzyme carnitine palmitoyltransferase (CPT)-1 are potential targets for the treatment of obesity. The modulation of CPT-1 may simultaneously affect energy metabolism and food intake to aid in the management of obesity. Both the inhibition and enhancement of CPT-1 activity are currently under investigation as strategies for the treatment of obesity. In this review, key data on both sides of the 'CPT-1 activity balance' as they relate to obesity therapy are discussed.",
keywords = "Carnitine palmitoyltransferase-1, CPT-1 inhibition, CPT-1 stimulation, Fatty acid oxidation, Feeding behavior, Malonyl-CoA, Obesity",
author = "Kuhajda, {Francis P.} and Ronnett, {Gabriele V.}",
year = "2007",
month = "4",
language = "English (US)",
volume = "8",
pages = "312--317",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity

AU - Kuhajda, Francis P.

AU - Ronnett, Gabriele V.

PY - 2007/4

Y1 - 2007/4

N2 - The rising incidence of obesity, as a disorder of energy metabolism, has provoked a search for pharmacological agents that either increase energy expenditure or reduce food intake. The fatty acid oxidation pathway, and its rate-limiting enzyme carnitine palmitoyltransferase (CPT)-1 are potential targets for the treatment of obesity. The modulation of CPT-1 may simultaneously affect energy metabolism and food intake to aid in the management of obesity. Both the inhibition and enhancement of CPT-1 activity are currently under investigation as strategies for the treatment of obesity. In this review, key data on both sides of the 'CPT-1 activity balance' as they relate to obesity therapy are discussed.

AB - The rising incidence of obesity, as a disorder of energy metabolism, has provoked a search for pharmacological agents that either increase energy expenditure or reduce food intake. The fatty acid oxidation pathway, and its rate-limiting enzyme carnitine palmitoyltransferase (CPT)-1 are potential targets for the treatment of obesity. The modulation of CPT-1 may simultaneously affect energy metabolism and food intake to aid in the management of obesity. Both the inhibition and enhancement of CPT-1 activity are currently under investigation as strategies for the treatment of obesity. In this review, key data on both sides of the 'CPT-1 activity balance' as they relate to obesity therapy are discussed.

KW - Carnitine palmitoyltransferase-1

KW - CPT-1 inhibition

KW - CPT-1 stimulation

KW - Fatty acid oxidation

KW - Feeding behavior

KW - Malonyl-CoA

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=34147129533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147129533&partnerID=8YFLogxK

M3 - Article

C2 - 17458181

AN - SCOPUS:34147129533

VL - 8

SP - 312

EP - 317

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 4

ER -